End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -3.35% | -4.04% | -8.18% |
06/06 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
05/06 | Can-Fite Biopharma Ltd. Updates on Its Advanced Liver Cancer Pivotal Phase 3 Study | CI |
Sales 2024 * | 9L 7.52Cr | Sales 2025 * | 9L 7.52Cr | Capitalization | 1.19Cr 100Cr |
---|---|---|---|---|---|
Net income 2024 * | -70L -58Cr | Net income 2025 * | -80L -67Cr | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 13.3 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on Can-Fite BioPharma Ltd.
1 day | -3.35% |
Managers | Title | Age | Since |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01/03/01 |
Pnina Fishman
FOU | Founder | 74 | 11/94/11 |
Ilan Cohn
FOU | Founder | 68 | 11/94/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01/01/01 |
Ilan Cohn
FOU | Founder | 68 | 11/94/11 |
Pnina Fishman
FOU | Founder | 74 | 11/94/11 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 9.19TCr | |
-1.32% | 3.87TCr | |
-12.88% | 3.28TCr | |
+64.51% | 2.67TCr | |
-16.31% | 1.53TCr | |
-11.38% | 1.17TCr | |
+173.10% | 1.04TCr | |
-49.84% | 1.01TCr | |
+4.34% | 906.11Cr |
- Stock Market
- Equities
- CANF Stock
- CANF Stock